참고문헌
- Shils ME, Young VR. 1988. Modern nutrition in health and disease. 7th ed. Lea and Febiger Publisher, Philadelphia. p 763
- Christenson RH. 1997. Biochemical markers of bone metabolism: an overview. Clin Biochem 30: 573-593 https://doi.org/10.1016/S0009-9120(97)00113-6
- Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. 1990. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption and bone loss at tissue and cellular levels. J Bone Miner Res 5: 311-319 https://doi.org/10.1002/jbmr.5650050402
- Prestwood KM, Pilbeam CC, Raisz LG. 1995. Treatment of osteoporosis. Annu Rev Med 46: 249-256 https://doi.org/10.1146/annurev.med.46.1.249
- Anderson JJ, Garner SC. 1998. Phytoestrogen and bone. Baillieres Clin Endocrinol Metab 12: 543-557 https://doi.org/10.1016/S0950-351X(98)80003-7
- Lindsay R. 1993. Pathogenesis of postmenopausal osteoporosis. Baillieres Clin Rheumato 7: 499-513 https://doi.org/10.1016/S0950-3579(05)80075-5
- Gallagher JC, Bishop CW, Knutson JC, Mazess RB, DeLuca HF. 1994. Effects of increasing doses of 1 alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women. J Bone Miner Res 9: 607-614
- Ettinger B, Genant HK, Cann CE. 1985. Long-term estrogen replacement therapy prevents bone loss and fracture. Ann Intern Med 102: 319-324 https://doi.org/10.7326/0003-4819-102-3-319
-
Edward MW, Bain SD, Bailey MC, Lantry MM, Howard GA. 1992. 17
$\beta$ -estradiol stimulation of endosteal bone formation in the ovariectomized mouse: an animal model for evaluation of bone targeted estrogens. Bone 13: 29-34 https://doi.org/10.1016/8756-3282(92)90358-4 - Ernst M, Heath JK, Rodan GA. 1989. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125: 825-833 https://doi.org/10.1210/endo-125-2-825
- Tomkinson A, Reeve J, Shaw RW, Noble BS. 1997. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 3128-3135 https://doi.org/10.1210/jc.82.9.3128
- Vedi S, Purdie DW, Ballard P, Bord S. Cooper AC, Compston JE. 1999. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Osteoporos Int 10: 52-58 https://doi.org/10.1007/s001980050194
- McCarthy TL, Centrella M. 1993. Regulation of IGF activity in bone. Adv Exp Med Bio 343: 407-414
- Genant HK, Baylink DJ, Gallagher JC. 1989. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161: 1842-1846 https://doi.org/10.1016/S0002-9378(89)80004-3
- Murphy LJ, Ghahary A. 1990. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocrine Rev 11: 443-453 https://doi.org/10.1210/edrv-11-3-443
- Anderson JJ, Garner SC 1998. Phytoestrogen and bone. Baillieres Clin Endocrinol Metab 12: 543-557 https://doi.org/10.1016/S0950-351X(98)80003-7
- Adlercreutz H, Mazur W. 1997. Phyto-oestrogens and Western diseases. Ann Med 29: 95-120 https://doi.org/10.3109/07853899709113696
- Setchell KDR. 1998. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333-1346 https://doi.org/10.1093/ajcn/68.6.1333S
- Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. 1999. Health potential of soy isoflavones for menopausal women. Public Health Nut 2: 489-504
- Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. 2001. Soy bean ethanol extract increases the function of osteoblastic MC3T3-El cells. Phytochemistry 56: 733-739 https://doi.org/10.1016/S0031-9422(00)00484-2
- Setchell KDR, Cassidy A. 1999. Dietary isoflavones: biological effects and relevance to human health. J Nutr 129: 758-767 https://doi.org/10.1093/jn/129.3.758S
- Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja Sc. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167 https://doi.org/10.1093/jn/126.1.161
- Gao YH, Yamaguchi M. 1999. Anabolic effect of daidzein on cortical in tissue culture: Comparison with genistein effect. Mol Cell Biochem 194: 93-98 https://doi.org/10.1023/A:1006949912266
- Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. 1998. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375-1379 https://doi.org/10.1093/ajcn/68.6.1375S
- Panti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH. 1998 The phytoestrogen genistein reduces bone loss in short-term ovariactomized rats. Osteoporo Int 8: 274-281 https://doi.org/10.1007/s001980050065
- Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167 https://doi.org/10.1093/jn/126.1.161
- Gehm BD, McAndrews JM, Chien PY, Jameson JL. 1997. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143
- Mizutani K, Ikeda K, Kawai Y, Yamori Y. 1998. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-El cells. Biochem Biophys Res Commun 253: 859-863 https://doi.org/10.1006/bbrc.1998.9870
- Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP. 2000. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130: 1675-1681
- Ljunghall S, Lindh E. 1989. Assesment of bone turnover with biochemical makers. J Intern Med 225: 219-220 https://doi.org/10.1111/j.1365-2796.1989.tb00069.x
- Wlodarski KH, Reddi AH. 1986. Alkaline phosphatase as a marker of osteoinductive cells. Calcif Tissue Int 39: 382-385 https://doi.org/10.1007/BF02555175
- Sugimoto E, Yamaguchi M. 2000a. Anabolic effect of genistein in osteoblastic MC3T3-El cells. Int J Mol Med 5: 515-520
- Sugimoto E, Yamaguchi M. 2000b. Stimulatory effect of daidzein in osteoblastic MC3T3-El cells. Biochem Pharmacol 59: 471-475 https://doi.org/10.1016/S0006-2952(99)00351-2
- Ernst M, Rodan GA. 1991. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 8: 1081-1089
- Nasu M, Sugimoto T, Kaji H, Chihara K. 2000. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cell: role of insulin like growth factor (IGF)-I and IGF-binding prtein-5. J Endocrinol 167: 305-313 https://doi.org/10.1677/joe.0.1670305
- Huynh H. 1998. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor 1. Int J Oncol 12: 427-432
- Shinar DM, Endo N, Halperin D, Rodan GA, Weinreb M. 1993. Differential expression of insulin-like growth factor-1 (IGF-I) and IGF-II messenger ribonucleic acid in rowin rat bone. Endocrinology 132: 1158-1167 https://doi.org/10.1210/en.132.3.1158
- Lazowski D, Fraher L, Hodsman A, Steer B, Modrowski D, Han V. 1994. Regional variation of insulin like growth factor-I gene expression in mature rat bone and cartilage. Bone 15: 563-576 https://doi.org/10.1016/8756-3282(94)90282-8
피인용 문헌
- Effects of daidzein on performance, serum metabolites, nutrient digestibility, and fecal bacterial community in bull calves vol.225, 2017, https://doi.org/10.1016/j.anifeedsci.2017.01.014
- Natural Substance MS-10 Improves Women's Health via Regulation of Estrogen Receptor vol.45, pp.6, 2016, https://doi.org/10.3746/jkfn.2016.45.6.903